Join the club for FREE to access the whole archive and other member benefits.

NIH awarded OMRF $3 million to study anti-aging abilities of a diabetic drug


Key points from article :

The National Institutes of Health has awarded the Oklahoma Medical Research Foundation $3 million to continue the study of the anti-aging abilities of a diabetes drug.

The five-year grant will allow Benjamin Miller, to continue his investigation of the ability of metformin, a diabetes drug, to slow the biological process of aging.

“We know exercise slows the aging process, but this drug could be an alternative for otherwise healthy people who don’t get much movement,” Miller said.

The study will observe metformin’s impact on animal models with different fitness levels.

Investigation of ability of metformin, a diabetic drug to slow the process of aging

Mentioned in this article:

Click on resource name for more details.

Benjamin Miller

Researcher in the Aging and Metabolism Research Program at OMRF.

National Institutes of Health (NIH)

Medical research agency that supports scientific studies

Oklahoma Medical Research Foundation (OMRF)

Biomedical research institute developing effective treatments for different human diseases.